Real-World Study Reveals Early Success of Upadacitinib in AD
TOPLINE:Upadacitinib was well tolerated in patients with moderate to severe atopic dermatitis (AD) and led to disease control as early...
Lloyd Culton
TOPLINE:Upadacitinib was well tolerated in patients with moderate to severe atopic dermatitis (AD) and led to disease control as early...
